Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the study record history. The earlier revision (v3.6.0) was removed from the visible history, updating the record's version history.
    Difference
    0.1%
    Check dated 2026-06-26T11:39:01.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Recruitment status was updated to not recruiting. The history now shows a new revision: v3.6.0, with the prior revision v3.5.5 removed.
    Difference
    0.4%
    Check dated 2026-06-11T23:24:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the history, and the previous revision v3.5.4 was removed from the history.
    Difference
    0.1%
    Check dated 2026-06-05T00:20:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 has been added to the study's record history, and the older entry v3.5.3 has been removed. This update reflects an adjustment to the visible version history of the record rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-21T17:18:27.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the record history. The previous revision v3.5.2 was removed from the list.
    Difference
    0.1%
    Check dated 2026-04-30T04:17:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page updates its displayed software revision from v3.5.0 to v3.5.2. No trial-specific content changes are shown.
    Difference
    0.1%
    Check dated 2026-04-22T18:25:19.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.